Delivery Order SPE2DR25D2104-SPE2DR26F3NLC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,855.22 to AmerisourceBergen Drug Corp for XHANCE 93 microgram nasal spray (16 milliliters) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,668.46 to AmerisourceBergen Drug Corp for XHANCE 93 MCG Nasal Spray (16ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical supplier within the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for Xhance 93 micrograms nasal spray (16 milliliters) with a ceiling value of $3,221.73. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $11,725.96 delivery order to AmerisourceBergen Drug Corp for XHANCE 93 MCG nasal spray (16 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,662.60 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16ml) on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $4,547.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Xhance 93 microgram nasal spray (16 milliliters). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $1,212.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xhance 93 mcg nasal spray (16 mL). This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Xhance 93 microgram nasal spray in 16-milliliter units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing with a ceiling value of $3,180.19 and an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $583 to Amerisourcebergen Drug Corporation for XHANCE 93 mcg nasal spray. The prime contractor will deliver 16mL bottles of the nasal spray to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA programs. Amerisourcebergen will perform the order itself, as no subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NLCDelivery Order
The Defense Logistics Agency awarded a $5,049.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XHANCE 93 MCG nasal spray (16 mL) on November 5, 2025, with completion targeted for November 6, 2025. This competitive award, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The SPE2DX prime vendor contract enables the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. This delivery order for XHANCE nasal spray supports the DLA Medical Supply Chain's ongoing pharmaceutical procurement requirements for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/5/25 |